Tranexamic acid injection for treatment of severe haemorrhage

Provenance

Created by SPS, the National Ambulance Service Medical Directors (NASMeD) and the Joint Royal Colleges Ambulance Liaison Committee (JRCALC), for medicines commonly supplied or administered within ambulance services commissioned by NHS England.

Planned Review

The tranexamic acid PGD template expired at the end of April 2026 and has been removed from this page.

The clinical conditions to be treated with tranexamic acid have been reviewed by JRCALC and the supporting guidance updated.  The timing of this update to the guidance did not allow for the PGD template to be reviewed and approved by NASMeD and the SPS MGDO Programme Board prior to the expiry of the last published template.

The PGD template is currently being updated by the expert Short Life Working Group. It is expected that the updated PGD template will be submitted to the SPS MGDO Programme Board in July 2026 for consideration and, if approved, published before the end of July 2026.

More ambulance services templates

• Diazepam injection for seizures or symptomatic cocaine toxicity management
• Rectal diazepam for managing seizures
• Buccal midazolam for seizures or symptomatic cocaine toxicity management
• Flumazenil injection for reversal of midazolam

All PGD templates

Update history